Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 4, 2011, Pages 656-662

  Jeganathan, Reubendra ^a   McGuigan, James ^a   Campbell, Frederick ^b   Lynch, Thomas ^c  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b Centre for Cancer Research and Cell Biology   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Oesophageal cancer; PET CT; Radiotherapy planning; Tumour length

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ESOPHAGUS CARCINOMA; HISTOPATHOLOGY; HUMAN; MAXIMUM STANDARDIZED UPTAKE VALUE; MEASUREMENT; PARAMETER; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; TREATMENT PLANNING; TUMOR VOLUME; VISUAL ANALYSIS;

ADULT; AGED; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 79953695930     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1670-3     Document Type: Article

References (35)

1. Office of National Statistics. Mortality statistics: cause, England and Wales 2007. London TSO 2009
2. Northern Ireland Cancer Registry. Cancer mortality in Northern Ireland 2007
3. ISD Online 2009. Cancer mortality in Scotland 2007
4. P Thomas C Doddoli P Lienne N Morati X Thirion L Garbe, et al. 1997 Changing patterns and surgical results in adenocarcinoma of the oesophagus Br J Surg 84 1 119 125 9043475 10.1002/bjs.1800840143 1:STN:280:DyaK2s7ps1aqtg%3D%3D (Pubitemid 27033126)
5. MA Eloubeidi R Desmond MR Arguedas CE Reed CM Wilcox 2002 Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status Cancer 95 7 1434 1443 12237911 10.1002/cncr.10868
6. EA Griffiths Z Brummell G Gorthi SA Pritchard IM Welch 2006 Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses J Surg Oncol 93 4 258 267 16496364 10.1002/jso.20449 (Pubitemid 43329818)
7. H Kato H Kuwano M Nakajima T Miyazaki M Yoshikawa H Ojima, et al. 2002 Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma Cancer 94 4 921 928 11920459 10.1002/cncr.10330 (Pubitemid 34150845)
8. MP Mac Manus RJ Hicks DL Ball V Kalff JP Matthews E Salminen, et al. 2001 F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment Cancer 92 4 886 895 11550162 10.1002/1097-0142(20010815)92:4<886::AID-CNCR1397>3.0.CO;2-V 1:STN:280:DC%2BD3MvpvFansg%3D%3D (Pubitemid 32783077)
9. K Mah CB Caldwell YC Ung CE Danjoux JM Balogh SN Ganguli, et al. 2002 The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study Int J Radiat Oncol Biol Phys 52 2 339 350 11872279 10.1016/S0360-3016(01)01824-7 (Pubitemid 34172999)
10. J Bradley WL Thorstad S Mutic TR Miller F Dehdashti BA Siegel, et al. 2004 Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 59 1 78 86 15093902 10.1016/j.ijrobp.2003.10.044 (Pubitemid 38501510)
11. M Morota K Gomi T Kozuka K Chin M Matsuura M Oguchi, et al. 2009 Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma Int J Radiat Oncol Biol Phys 75 1 122 128 19327900 10.1016/j.ijrobp.2008.10.075
12. LB Marks X Yu Z Vujaskovic W Small Jr R Folz MS Anscher 2003 Radiation-induced lung injury Semin Radiat Oncol 13 3 333 345 12903021 10.1016/S1053-4296(03)00034-1 (Pubitemid 36966158)
13. G Gagliardi I Lax LE Rutqvist 2001 Partial irradiation of the heart Semin Radiat Oncol 11 3 224 233 11447579 10.1053/srao.2001.23483 1:STN:280: DC%2BD3MzptlSgtw%3D%3D (Pubitemid 32652414)
14. JF Daisne T Duprez B Weynand M Lonneux M Hamoir H Reychler, et al. 2004 Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen Radiology 233 1 93 100 15317953 10.1148/radiol.2331030660 (Pubitemid 39280962)
15. JD Kiffer SU Berlangieri AM Scott G Quong M Feigen W Schumer, et al. 1998 The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer Lung Cancer 19 3 167 177 9631364 10.1016/S0169-5002(97)00086-X 1:STN:280:DyaK1c3psVyhtw%3D%3D (Pubitemid 28238467)
16. T Leong C Everitt K Yuen S Condron A Hui SY Ngan, et al. 2006 A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer Radiother Oncol 78 3 254 261 16545881 10.1016/j.radonc.2006.02.014
17. X Zhong J Yu B Zhang D Mu W Zhang D Li, et al. 2009 Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys 73 1 136 141 18538492 10.1016/j.ijrobp.2008.04.015
18. M Mamede G El Fakhri P Abreu-e-Lima W Gandler V Nosé VH Gerbaudo 2007 Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation Ann Nucl Med 21 10 553 562 18092131 10.1007/s12149-007-0040-0 (Pubitemid 350293594)
19. D Han J Yu Y Yu G Zhang X Zhong J Lu, et al. 2010 Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus Int J Radiat Oncol Biol Phys 76 4 1235 1241 19910143 10.1016/j.ijrobp.2009.07.1681
20. JM Bland DG Altman 1986 Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 8476 307 310 2868172 1:STN:280:DyaL287hslWqsQ%3D%3D (Pubitemid 16134762)
21. DR Sun 1989 Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients Int J Radiat Oncol Biol Phys 16 2 329 334 2921133 10.1016/0360-3016(89)90324-6 1:STN:280:DyaL1M7lsFaitA%3D%3D
22. GA Newaishy GA Read W Duncan GR Kerr 1982 Results of radical radiotherapy of squamous cell carcinoma of the oesophagus Clin Radiol 33 3 347 352 7075142 10.1016/S0009-9260(82)80288-2 1:STN:280:DyaL387osFenug%3D%3D (Pubitemid 12114598)
23. T Okawa M Kita M Tanaka M Ikeda 1989 Results of radiotherapy for inoperable locally advanced esophageal cancer Int J Radiat Oncol Biol Phys 17 1 49 54 2745207 10.1016/0360-3016(89)90369-6 1:STN:280:DyaL1MzgvVWmug%3D%3D (Pubitemid 19173237)
24. TS Hong JH Killoran M Mamede HJ Mamon 2008 Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning Int J Radiat Oncol Biol Phys 72 5 1612 1618 19028285 10.1016/j.ijrobp.2008.07.061
25. YE Erdi H Macapinlac KE Rosenzweig JL Humm SM Larson AK Erdi, et al. 2000 Use of PET to monitor the response of lung cancer to radiation treatment Eur J Nucl Med 27 7 861 866 10952499 10.1007/s002590000258 1:STN:280: DC%2BD3M%2Fot1aqtA%3D%3D (Pubitemid 30456770)
26. MP Mac Manus RJ Hicks JP Matthews A McKenzie D Rischin EK Salminen, et al. 2003 Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer J Clin Oncol 21 7 1285 1292 12663716 10.1200/JCO.2003.07.054 (Pubitemid 46606405)
27. M Yao MM Graham HT Hoffman RB Smith GF Funk SM Graham, et al. 2004 The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 59 4 1001 1010 15234033 10.1016/j.ijrobp.2004.01.040 (Pubitemid 38834292)
28. JB Roedl DV Sahani RR Colen AJ Fischman PR Mueller MA Blake 2008 Tumour length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in oesophageal cancer Eur Radiol 18 12 2833 2840 18651155 10.1007/s00330-008-1078-7
29. A van Baardwijk BG Baumert G Bosmans M van Kroonenburgh S Stroobants V Gregoire, et al. 2006 The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning Cancer Treat Rev 32 4 245 260 16563636 10.1016/j.ctrv.2006.02.002 (Pubitemid 44502002)
30. A Konski M Doss B Milestone O Haluszka A Hanlon G Freedman, et al. 2005 The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma Int J Radiat Oncol Biol Phys 61 4 1123 1128 15752892 10.1016/j.ijrobp.2004.07. 717 (Pubitemid 40340906)
31. KF Siu HC Cheung J Wong 1986 Shrinkage of the esophagus after resection for carcinoma Ann Surg 203 2 173 176 3947154 10.1097/00000658-198602000-00011 1:STN:280:DyaL287ivFKisQ%3D%3D (Pubitemid 16144705)
32. O Vrieze K Haustermans W De Wever T Lerut E Van Cutsem N Ectors, et al. 2004 Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? Radiother Oncol 73 3 269 275 15588870 10.1016/j.radonc.2004.10.001 (Pubitemid 39601073)
33. V Gondi K Bradley M Mehta A Howard D Khuntia M Ritter, et al. 2007 Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer Int J Radiat Oncol Biol Phys 67 1 187 195 17189070 10.1016/j.ijrobp.2006.09.033 (Pubitemid 44959515)
34. D Vesprini Y Ung R Dinniwell S Breen F Cheung D Grabarz, et al. 2008 Improving observer variability in target delineation for gastro-oesophageal cancer-the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography Clin Oncol R Coll Radiol 20 8 631 638 18755578 1:STN:280:DC%2BD1cngtFKisg%3D%3D
35. L Moureau-Zabotto E Touboul D Lerouge E Deniaud-Alexandre D Grahek JN Foulquier, et al. 2005 Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma Int J Radiat Oncol Biol Phys 63 2 340 345 16168829 10.1016/j.ijrobp.2005.02.039 (Pubitemid 41317149)